Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$517M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$516M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$306M |
| 4 |
Meta Platforms (Facebook)
META
|
+$296M |
| 5 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$441M |
| 2 |
Duke Energy
DUK
|
+$407M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$267M |
| 4 |
Alibaba
BABA
|
+$245M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.71% |
| 2 | Financials | 4.45% |
| 3 | Healthcare | 3.9% |
| 4 | Communication Services | 2.83% |
| 5 | Consumer Discretionary | 2.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4526
Vanguard Total World Stock ETF
VT
$79.2B
| $124K | ﹤0.01% |
2,035
| – | – |
|
4527
Onto Innovation
ONTO
$13.7B
| $123K | ﹤0.01% |
4,867
-5,389
| -53% | -$123K |
|
|
JUNO
4528
CALL
DELISTED
Juno Therapeutics, Inc.
JUNO
| $123K | ﹤0.01% |
6,500
-182,600
| -97% | -$4.47M |
|
|
ARR
4529
Armour Residential REIT
ARR
$2.35B
| $122K | ﹤0.01% |
1,126
+949
| +536% | +$105K |
|
4530
CALL
Edison International
EIX
$26.3B
| $122K | ﹤0.01% |
1,700
-51,100
| -97% | -$3.61M |
|
|
FONR
4531
DELISTED
Fonar
FONR
| $122K | ﹤0.01% |
6,400
-20,100
| -76% | -$389K |
|
4532
PUT
iShares US Financials ETF
IYF
$4.63B
| $122K | ﹤0.01% |
+2,400
| New | +$115K |
|
4533
M/I Homes
MHO
$3.81B
| $122K | ﹤0.01% |
4,848
+402
| +9% | +$9.47K |
|
4534
OSI Systems
OSIS
$3.87B
| $122K | ﹤0.01% |
1,593
-9,744
| -86% | -$703K |
|
4535
PUT
Rocket Pharmaceuticals
RCKT
$382M
| $122K | ﹤0.01% |
+5,000
| New | +$143K |
|
4536
Teekay
TK
$946M
| $122K | ﹤0.01% |
15,259
+4,391
| +40% | +$33.8K |
|
4537
PUT
Veeva Systems
VEEV
$34.7B
| $122K | ﹤0.01% |
3,000
-1,700
| -36% | -$69.4K |
|
|
CFMS
4538
CALL
DELISTED
Conformis, Inc. Common Stock
CFMS
| $122K | ﹤0.01% |
+600
| New | +$133K |
|
|
NILE
4539
PUT
DELISTED
Blue Nile, Inc.
NILE
| $122K | ﹤0.01% |
3,000
+1,900
| +173% | +$72.7K |
|
4540
ProShares Ultra Silver
AGQ
$1.29B
| $121K | ﹤0.01% |
3,759
-10,627
| -74% | -$403K |
|
4541
CALL
Alto Ingredients
ALTO
$392M
| $121K | ﹤0.01% |
12,700
+11,700
| +1,170% | +$94K |
|
4542
Atara Biotherapeutics
ATRA
$76.9M
| $121K | ﹤0.01% |
347
+332
| +2,213% | +$141K |
|
4543
CALL
Cincinnati Financial
CINF
$27.3B
| $121K | ﹤0.01% |
1,600
+200
| +14% | +$14.9K |
|
4544
PUT
Dana Inc
DAN
$3.01B
| $121K | ﹤0.01% |
6,400
+4,000
| +167% | +$66.9K |
|
|
SNMP
4545
DELISTED
Evolve Transition Infrastructure LP
SNMP
| $121K | ﹤0.01% |
+343
| New | +$131K |
|
|
PTLA
4546
CALL
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $121K | ﹤0.01% |
+5,400
| New | +$105K |
|
4547
CALL
Darling Ingredients
DAR
$9.19B
| $120K | ﹤0.01% |
9,300
-7,400
| -44% | -$100K |
|
4548
FerroAtlántica
GSM
$775M
| $120K | ﹤0.01% |
11,113
+10,600
| +2,066% | +$109K |
|
4549
Hovnanian Enterprises
HOV
$808M
| $120K | ﹤0.01% |
1,745
+779
| +81% | +$39K |
|
4550
PUT
Iron Mountain
IRM
$37.8B
| $120K | ﹤0.01% |
3,700
+300
| +9% | +$9.97K |
|
Similar funds
Barclays's Q4 2016 Portfolio in Review
As of Q4 2016, Barclays held 7,178 positions worth $92.5B, up 2.7% from $90.1B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays's Q4 2016 filing shows 490 new, 3,383 increased, 2,405 reduced and 438 closed positions. Its largest new stake was Howmet Aerospace: 1,639,920 shares worth $23.3M. The largest sale was Procter & Gamble, an estimated $441M.
By sector, the portfolio is most concentrated in Technology at 4.7% of assets, up from 4.5% a quarter earlier, followed by Financials and Healthcare.
- Barclays's largest Q4 2016 buy was Howmet Aerospace: 1,639,920 shares worth $23.3M.
- Barclays added most to State Street Technology Select Sector SPDR ETF in Q4 2016, an estimated $517M increase.
- Barclays's biggest Q4 2016 reduction was Procter & Gamble, cutting an estimated $441M.
- Barclays fully exited LinkedIn Corporation in Q4 2016, selling an estimated $223M.
- Barclays's ten largest holdings make up 34% of its $92.5B portfolio in Q4 2016.
- Barclays opened 490 new positions and closed 438 in Q4 2016.
- Barclays's portfolio value rose 2.7% quarter-over-quarter to $92.5B.
Based on Barclays's 13F filing for Q4 2016, filed 14 Feb 2017.